Sharon Townson
Chief Tech/Sci/R&D Officer bei MONTE ROSA THERAPEUTICS, INC.
Profil
Sharon Townson is currently the Chief Technology Officer at Monte Rosa Therapeutics, Inc. She previously worked as the Scientific Director-Physical Biochemistry at Warp Drive Bio, Inc. from 2016 to 2018 and as the Executive Director & Head-Platform Biology at Kymera Therapeutics, Inc. from 2019 to 2020.
Dr. Townson obtained her undergraduate degree from the University of Salford and her doctorate degree from the University of Manchester Institute of Science & Technology.
Aktive Positionen von Sharon Townson
| Unternehmen | Position | Beginn |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Sharon Townson
| Unternehmen | Position | Ende |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 01.06.2020 |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.12.2018 |
Ausbildung von Sharon Townson
| University of Salford | Undergraduate Degree |
| University of Manchester Institute of Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
